GB2384707A — Compositions for treatment of nausea, vomiting, emesis, motion sickness or like conditions
Assigned to GW Pharma Ltd · Expires 2003-08-06 · 23y expired
What this patent protects
A cannabinoid acid, in particular CBD and CBDA and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness. Extracts of cannabis plants are presented which are rich in these substances and sui…
USPTO Abstract
A cannabinoid acid, in particular CBD and CBDA and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness. Extracts of cannabis plants are presented which are rich in these substances and suitable for pharmaceutical use.
Drugs covered by this patent
- Epidiolex (CANNABIDIOL) · Jazz Pharms Res
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.